The results showed that β-galactosidase activity was significantly reduced and cellular DNA MMR activity was increased in bladder cancer cells with knockdown of RAB23 compared with the control group (Fig. 7C). This evidence concerns the gene RAB23 and urinary bladder carcinoma.